Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Ieper – page 100

1 838 clinical trials in Ieper, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Ieper at a glance
1 838
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 838 trials in Ieper

Open in trial search

Cardiac amyloidosis

Not recruiting

Study of Patisiran for Patients with Transthyretin Amyloidosis and Heart Disease

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Patisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Alcoholism

Not recruiting

Study on Cannabidiol for Reducing Alcohol Consumption in Patients with Alcohol Use Disorder

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Cannabidiol
  • Sponsor:Centre Hospitalier Le Vinatier

Breast cancer+1

Not recruiting

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Study of Axatilimab for Patients with Chronic Graft Versus Host Disease After Two Prior Treatments

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Axatilimab
  • Sponsor:Syndax Pharmaceuticals Inc.

Study of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Degarelix
  • Sponsor:Debiopharm International S.A.

Hepatic cirrhosis

Not recruiting

Study of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Resmetirom
  • Sponsor:Madrigal Pharmaceuticals Inc.

Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Tolebrutinib
  • Sponsor:Genzyme Corp.

Giant cell arteritis

Not recruiting

Study of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Prednisone
  • Sponsor:Novartis Pharma AG

Breast cancer+1

Not recruiting

Study of Tucatinib and Ado-Trastuzumab Emtansine for Patients with Advanced HER2+ Breast Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tucatinib
  • Sponsor:Seagen Inc.

Study on MaaT013 for Treating Acute Gastrointestinal Graft-Versus-Host Disease in Patients Not Responding to Ruxolitinib

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Allogeneic Faecal Microbiota, Pooled
  • Sponsor:Maat Pharma

Study Comparing Lazertinib and Subcutaneous Amivantamab with Intravenous Amivantamab for Patients with EGFR-mutated Advanced or Metastatic Non-small Cell Lung Cancer

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen Cilag International

Plasma cell myeloma

Not recruiting

Study of Teclistamab with Daratumumab or Lenalidomide for Elderly Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Daratumumab
  • Sponsor:Centre Hospitalier Universitaire De Lille

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Ieper

What the registry says about research in the country

01 Infectious Disease Prevention

Research focusing on developing and evaluating vaccines against influenza and respiratory syncytial virus in various age groups. Multiple trials are investigating immune responses and safety profiles in both younger and older adults.

  • Influenza vaccine studies in adults 60+ years
  • RSV vaccine trials for elderly population
  • UTI vaccine development

Advanced clinical research aims to enhance protection against common respiratory infections and urinary tract pathogens.

02 Kidney Disease Management

Comprehensive studies evaluating innovative treatments for chronic kidney disease (CKD), particularly in patients with concurrent conditions like hypertension and diabetes.

  • Combined therapy approaches
  • Novel drug evaluations
  • Albumin reduction strategies

Multiple trials are exploring combination therapies and new compounds to improve outcomes in CKD patients.

03 Cardiovascular and Metabolic Disorders

Innovative research addressing cardiovascular conditions and metabolic disorders, including studies on atrial fibrillation and diabetes prevention.

  • Post-gestational diabetes interventions
  • Atherosclerotic disease in ESKD
  • Antiplatelet therapy optimization

Trials focus on both preventive measures and treatment strategies for complex cardiovascular conditions.

04 Oncology Research

Advanced studies in cancer treatment, particularly focusing on mantle cell lymphoma and endometrial cancer therapies.

  • Lymphoma combination treatments
  • Endometrial cancer maintenance therapy
  • Novel therapeutic approaches

Research aims to improve treatment outcomes through innovative drug combinations and maintenance strategies.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.